Tag Archives: Announces

Rajant Announces Cardinal Module Integrated Into UVify OMEGA Drone Platform

Visit Rajant with UVify at Xponential Booth 1734 Malvern, PA – May 9, 2023: Rajant Corporation, the pioneer of Kinetic Mesh® wireless, will announce the integration of its latest credit card-sized dual-radio Cardinal module with UVify’s OMEGA drone platform at Xponential May 8th – 11th in Denver, Colorado. The Cardinal is powerful, lightweight, and notably… Read More »

The Infinigate Group Announces a New Brand for the Next Era of Expansion

Rotkreuz, Switzerland: 27/04/23. The Infinigate Group, the value-add distributor of cybersecurity, secure networks and secure cloud, is proud to announce a fresh brand, incorporating a new logo, tagline, colours and font, reflecting both its heritage and expansion and leading into a new era, as a cybersecurity distribution powerhouse across EMEA. The new brand expresses the… Read More »

Telent announces new Chairman

Warwick, U.K., September 5th 2022 – Telent Ltd, a leading UK technology and network services company, has announced the appointment of Paul Lester CBE as a Non-Executive Director and Chairman of the company. Paul joined the Board as of Friday 2 September 2022, succeeding David Naylor-Leyland who is stepping down as Chairman after 12 years… Read More »

Tessian Announces Allen Lieberman as its Chief Product Officer

Lieberman joins the Human Layer Security company from VMware Carbon Black 2 November 2021 – San Francisco. Tessian today welcomes Allen Lieberman as its Chief Product Officer. He will lead the continued development of the industry’s first and leading Human Layer Security platform, which uses machine learning to stop threats caused by human error like… Read More »

Jazz Pharmaceuticals Announces FDA Approval of Additional Indication for Vyxeos (daunorubicin and cytarabine) for the Treatment of Secondary Acute Myeloid Leukemia in Pediatric Patients

DUBLIN, March 30, 2021 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) approved a revised label for Vyxeos® (daunorubicin and cytarabine) to include a new indication to treat newly-diagnosed therapy-related acute myeloid leukemia (t-AML) or AML with myelodysplasia-related changes (AML-MRC) in pediatric patients aged one year and older. The approval of Vyxeos for this indication… Read More »